Clinical, biological, and outcome features of P2RY8-CRLF2 and CRLF2 over-expression in pediatric B-cell precursor acute lymphoblastic leukemia according to the CCLG-ALL 2008 and 2018 protocol.
Ying WangJun LiTian-Lin XueShuo TianZhi-Xia YueShu-Guang LiuChao GaoPublished in: European journal of haematology (2023)
These findings indicate P2RY8-CRLF2 identifies a subset of patients with specific features and adverse outcomes that could be improved by risk-directed treatment.